These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 28455847

  • 1. Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
    Okihara K, Yorozu A, Saito S, Tanaka N, Koga H, Higashide S, Kikuchi T, Nakano M.
    Int J Urol; 2017 Jul; 24(7):518-524. PubMed ID: 28455847
    [Abstract] [Full Text] [Related]

  • 2. Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy.
    Kikkawa K, Iba A, Kohjimoto Y, Noda Y, Sonomura T, Hara I.
    Int J Urol; 2018 Apr; 25(4):366-371. PubMed ID: 29397569
    [Abstract] [Full Text] [Related]

  • 3. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
    Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium, Michalski JM.
    Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):304-317. PubMed ID: 28463150
    [Abstract] [Full Text] [Related]

  • 4. Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: outcome and toxicity.
    Yamada Y, Masui K, Iwata T, Naitoh Y, Yamada K, Miki T, Okihara K.
    Brachytherapy; 2015 Jun 01; 14(2):118-23. PubMed ID: 25304650
    [Abstract] [Full Text] [Related]

  • 5. Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS).
    Koga H, Naito S, Ishiyama H, Yorozu A, Saito S, Kojima S, Higashide S, Kikuchi T, Nakamura K, Dokiya T, Fukushima M, J-POPS Study Group.
    Brachytherapy; 2019 Jun 01; 18(6):806-813. PubMed ID: 31378511
    [Abstract] [Full Text] [Related]

  • 6. Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS).
    Tanaka N, Yorozu A, Kikuchi T, Higashide S, Kojima S, Ohashi T, Katayama N, Nakamura K, Saito S, Dokiya T, Fukushima M, J-POPS Study Group.
    Brachytherapy; 2019 Jun 01; 18(4):484-492. PubMed ID: 31072729
    [Abstract] [Full Text] [Related]

  • 7. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
    Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ.
    Brachytherapy; 2015 Jun 01; 14(2):160-5. PubMed ID: 25255712
    [Abstract] [Full Text] [Related]

  • 8. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 01; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 9. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul 01; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of permanent brachytherapy combined with androgen deprivation therapy in an intermediate-risk prostate cancer group without a Gleason score of 4 + 3: a single Japanese institutional experience.
    Okihara K, Kobayashi K, Iwata T, Naitoh Y, Kamoi K, Kawauchi A, Yamada K, Miki T.
    Int J Urol; 2014 Mar 01; 21(3):271-6. PubMed ID: 24033545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Five-year potency preservation after iodine-125 prostate brachytherapy.
    Nishimura S, Yorozu A, Ohashi T, Sakayori M, Yagi Y, Nishiyama T, Saito S, Shiraishi Y, Yoshida K, Toya K, Shigematsu N.
    Int J Clin Oncol; 2014 Oct 01; 19(5):940-5. PubMed ID: 24170247
    [Abstract] [Full Text] [Related]

  • 15. Editorial Comment to Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
    Enatsu N.
    Int J Urol; 2017 Jul 01; 24(7):524. PubMed ID: 28560809
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
    Okaneya T, Nishizawa S, Nakayama T, Kamigaito T, Hashida I, Hosaka N.
    Int J Urol; 2007 Jul 01; 14(7):602-6. PubMed ID: 17645602
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal Changes in Health-related Quality of Life After 125I Low-dose-rate Brachytherapy for Localized Prostate Cancer.
    Ogasawara N, Nakiri M, Kurose H, Ueda K, Chikui K, Nishihara K, Matsuo M, Suekane S, Murotani K, Muraki K, Hattori C, Ogo E, Igawa T, Ishitake T.
    Anticancer Res; 2020 Nov 01; 40(11):6443-6456. PubMed ID: 33109583
    [Abstract] [Full Text] [Related]

  • 20. Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer.
    Nishihara K, Nakiri M, Chikui K, Suekane S, Matsuoka K, Hattori C, Ogo E, Abe T, Matsumoto Y, Ishitake T.
    Int J Urol; 2014 Jul 01; 21(7):658-63. PubMed ID: 24650159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.